Remepy Secures $36 Million in Latest Series D Funding Round

Remepy secured $36 million in its latest Series D, adding another data point to the FinTech funding market.

Remepy Raises $36 million in Funding

Remepy raises $36M to pair prescription drugs with therapeutic software. Remepy raised $36M to develop hybrid drugs combining traditional medications with therapeutic software.

Investors Behind the Funding

The round was backed by undisclosed investors. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

Remepy operates in FinTech. Remepy's financing adds to recent private-market activity.

Strategic Use of Funds

Pair prescription drugs with therapeutic software.

Looking Ahead

Remepy raises $36M to pair prescription drugs with therapeutic software

Source reference: original announcement/article.